x

Search for a clinical trial

* (*) mandatory field

Phase IIB, multicenter, randomized, open-label trial of CPX-351 (Cytarabine:Daunorubicin) liposome injection versus intensive salvage therapy in adult patients 60 years old with AML in first relapse following an initial CR > 1 month duration

  • Type of clinical trial : Drug clinical trial
  • Recruiting project : No
  • Status : Terminated trial
  • Funding body(ies) :
  • Geographic coverage : National
  • Sponsor : Celator pharmaceuticals, inc
  • Website
    • Phase : II
  • Principal investigator of clinical trial

  • INFORMATION NOT PROVIDED
  • Institution: Information not provided - FR
  • ADDRESS: NOT PROVIDED - FR
  • FRANCE
  • More information
  • Phone  : -
  • Fax  : -
Last update: June 2012

Additional information

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.